Showing results (241-250 of 471) with videos related to
Sort By:
Pageof 48
JAMA|November 25, 1997
Impact of a clinical guidelines program for breast and colon cancer in a French cancer centerI Ray-Coquard, T Philip, M Lehmann, et al.Chemistry and Physics of Lipids|December 31, 2002
Inhibition of pain responses by activation of CB(2) cannabinoid receptorsT Philip Malan, Mohab M Ibrahim, Todd W Vanderah, et al.Bone Marrow Transplantation|January 1, 1990
Effect of in vivo therapy with a CD8 monoclonal antibody on delayed engraftment after autologous bone marrow transplantationM Favrot, T Philip, V Combaret, et al.Leukemia Research|January 1, 1988
Cytogenetic evaluation of bone marrow involvement in Burkitt's lymphomaE Mark-Vendel, I Philip, T Philip, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study GroupD R Newell, A D Pearson, K Balmanno, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|May 23, 2018
Factors influencing the documentation of fertility-related discussions for adolescents and young adults with cancerG Skaczkowski, V White, K Thompson, et al.British Journal of Haematology|July 26, 2002
Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group RegistryC R Pinkerton, I Hann, C L Weston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group TrialH Thomas, A V Boddy, M W English, et al.Bulletin Du Cancer|January 1, 1988
[Value of immunological analysis for the detection of residual neuroblasts in the bone marrow]V Combaret, M C Favrot, C Bailly, et al.Internal Medicine Journal|July 12, 2016
Inconsistencies and time delays in site-specific research approvals hinder collaborative clinical research in AustraliaV M White, H Bibby, M Green, et al.Pageof 48